Macau Casino Gambli...
Health Care: Drugs
Aastrom Biosciences Inc. (ASTM: NASDAQ)
$1.96 -0.03 | -1.51%
06/01/12 - 03:59 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Jun 2010 | Jun 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -19.67M | -19.09M | -17.73M | -15.95M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 16.00K | -9.00K | 42.00K | -40.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 1.00K | -1.00K |
| (Increase) Decrease In Other Current Assets | -210.00K | -43.00K | 72.00K | 592.00K |
| (Decrease) Increase In Payables | 63.00K | 976.00K | 896.00K | -54.00K |
| (Decrease) Increase In Other Current Liabilities | 246.00K | 110.00K | 331.00K | -392.00K |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | -5.59M | 8.54M | 710.00K | 1.36M |
| Net Cash From Continuing Operations | -24.49M | -9.25M | -15.08M | -13.80M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -24.49M | -9.25M | -15.08M | -13.80M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 5.00M | 0.00 | 6.00M |
| Purchases of Property, Plant & Equipment | -1.03M | -305.00K | -120.00K | -35.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | -5.00M | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -1.03M | 4.70M | -5.12M | 5.96M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 32.00K | 21.80M | 17.53M | 8.53M |
| Repayment of Long-Term Debt | -227.00K | -119.00K | -479.00K | -445.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 277.00K | 259.00K |
| Net Cash From Financing Activities | -195.00K | 21.69M | 17.32M | 8.35M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -25.72M | 17.13M | -2.88M | 508.00K |
Portfolios with ASTM
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- Contributor10 Cheap Biotech Stocks Tha...
- Usermrtimrx WatchList
- UserMy Folly
- Userbosw119
- Usergellis1360 Portfolio 1
- UserSusu's Stocks
- UserRet2009
- Userspecialinterest
- Userpo boy
Latest ASTM Headlines from TheStreet
- Aastrom Raises Cash To Fund Pivotal Trial 03.09.12 | 12:03 pm
- More Biotech Twitter Mailbag: Orexigen, Affymax, YM Bio, Spectrum & More 02.29.12 | 07:02 am
- Aastrom CEO: Financing Close to Completion 01.18.12 | 08:01 am
- Aastrom Cell Therapy Reverses Effects of Blocked Leg Arteries 11.14.11 | 02:11 pm
- The Next Big Thing In Biotech: Aastrom
11.11.11 | 05:11 am - Biotech Calendar: Key Dates for November 11.01.11 | 10:11 am
- Biotech Calendar: Key Dates for September 08.31.11 | 06:08 am
- 10 Cheap Biotech Stocks That Could Soar 06.28.11 | 07:06 am
- Biotech Stock Mailbag: Live Chat 06.17.11 | 11:06 am
- Biotech Stock Mailbag: Aastrom BioSciences 06.03.11 | 06:06 am
Press Releases for ASTM
Partner Headlines for ASTM
- Follow the Analyst Leader: New Stock Coverage to Watch - Wall St. Cheat Sheet 05.31.12 | 04:05 am
- Medgenics Moving In Record Time - Seeking Alpha 05.21.12 | 09:05 am
- Aastrom Biosciences Announces Initiation of Patient Enrollment in REVIVE Phase 3 Clinical Trial of Ixmyelocel-T - Benzinga 02.29.12 | 04:02 pm
- 10 Biotech Stocks Undervalued By Levered Free Cash Flows - Seeking Alpha 12.07.11 | 08:12 am
- Aastrom Bio: Final RESTORE Data Looks Solid - Seeking Alpha 11.15.11 | 09:11 am
- 6 Recently Crushed Stocks With Heavy New Insider Buying - Seeking Alpha 08.14.11 | 09:08 am
- Analyst Interview - International Stem Cell - Analyst Blog - Zacks 07.27.11 | 06:07 am
- Aastrom Files At-the-Market Offering and New Shelf Registration Statement - Benzinga 06.16.11 | 04:06 pm
- Aastrom Biosciences' Trial Meets Safety and Efficacy Endpoints - Seeking Alpha 06.02.11 | 09:06 am
- 6 Speculative Biotech Stocks Smart Money Loves - Seeking Alpha 05.23.11 | 09:05 am
